SIGLEC1 and autoimmune disease: Significant changes in the numbers of CD169+ macrophages can be detected in human tissues, lymph nodes, and peripheral blood, particularly in neoplastic and autoimmune diseases.[37] Surface markers of CD169+ macrophages in lymph nodes include CD68, MHC type II, CD11c, CD11b, and F4/80.